반응형
구분 보고서(영문)
제약/바이오/
임상시험
(16건)		 Interim Results of IGNAZ Trial Sheds Positive Light on Felzartamab for IgAN
Verona Prepares for Anticipated US Launch of Ensifentrine for COPD in Q3 2024
Clinical Trial Landscape for Sub-Saharan Africa
Influx of Adoptive Cell Therapies May Be on the Horizon
Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)
Clinical Trials: Adoptive Cell Therapy
ASCO 2024: Merus Charging Ahead After Positive Results for Petosemtemab in HNSCC
ASCO 2024: Moderna’s Cancer Vaccine Poised to Redefine the Melanoma Landscape
ASCO 2024: Akeso’s Bispecific Ivonescimab Facing a Rocky Road Ahead in NSCLC
ASCO 2024: Survival Benefit for Subcutaneous Formulated Rybrevant
ASCO 2024: Enhertu is Aiming to Replace Herceptin in First-Line Metastatic Breast Cancer
ASCO 2024: Can Ambrx’s Novel ADC Break into the Metastatic Breast Cancer Market?
ASCO 2024: Tagrisso to Become New Standard of Care for Unresectable Stage III EGFR-mutated NSCLC
ARVO Conference Unveils Positive Vabysmo Data
AIFA’s Horizon Scanning 2024 Predictions Suggest Preparations for an Influx of ATMPs
Bio/Pharmaceutical Outsourcing Report, May 2024
질환별
(10건)		 Climate Change May Aggravate Major Neurological Disorders, Including Multiple Sclerosis
ASCO 2024: Practice-Changing Win for Opdivo Combo in Neoadjuvant Melanoma
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update
Androgenic Alopecia: Competitive Landscape
Insights on May: Osteoporosis Awareness & Prevention Month
Breyanzi Battles CAR-T Rivals with Back-to-Back Approvals in Lymphoma
MELAS Syndrome: Competitive Landscape
Genital Herpes: Competitive Landscape
7MM ADHD Market Forecast to Decline by $1 Billion Between 2022 and 2032
컨퍼런스/
심포지엄/
학회/기타
(2건)		 Manufacturing Inspections Down in China Amid Arrest Fears and No Access
AbbVie’s Strong Immunology Portfolio Forecast to Combat Humira Losses
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 7.5. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
반응형
구분 보고서(영문)
제약/바이오/
임상시험
(2건)		 Cervical Cancer Elimination in the UK Is Within Sight With HPV Vaccine
GLP-1 Receptor Agonist Sales Expected to Reach $125 Billion by 2033
질환별
(9건)		 Plaque Psoriasis: Seven-Market Drug Forecast and Market Analysis – Update
Dengue Transmission Spatial Dynamics in Brazil Investigated in New Study
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis
Arthritis Reduces Nutritional Status in the Elderly Population in Canada
TB Outbreak Spurs Public Health Emergency in California
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast
Bronchiectasis Opportunity Assessment and Forecast 2023-2033
Systemic Lupus Erythematosus: An Epidemiological Examination of Gender Differences
Video Chats Can Enhance Brain Functioning in Socially Isolated Elderly People
컨퍼런스/
심포지엄/
학회/기타
(1건)		 Necessity to Address the Unmet Mental Health Needs of Patients With Chronic Conditions
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
반응형
구분 보고서 (영문)
제약/바이오/
임상시험
(14건)		 Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
Interim Analysis of APPLAUSE-IgAN Trial Sheds Positive Light on Fabhalta for IgAN
World Immunization Week 2024: mRNA Vaccines Could Reduce Preventable Illness Across Multiple Disease Areas
The Privileged Status of Orphan Medicines in Germany
Key Opinion Leaders on GLP-1 Receptor Agonist Clinical Trial Design
APAC Leads in Clinical Trials for Asthma During 2019–23
AstraZeneca’s Fasenra: Approval for Asthma may initiate COPD Approval
Central Nervous System Remains Most Researched Therapy Area for DCTs
ESCMID Global 2024: Cutting-Edge Vaccines in Development for a Healthier Tomorrow
Jemperli Contends with Blockbuster Keytruda in Endometrial Cancer
FDA Approves Alecensa as Leading-Edge Adjuvant Therapy for ALK-Positive Lung Cancer
ESCMID Global 2024: Drug Resistance in Fungi – a Growing Issue
Insmed’s Brensocatib: A Candidate for Bronchiectasis Treatment, Closer to Approval
ESCMID Global 2024: Advances in Drug Resistance Testing
질환별
(9건)		 Friedreich Ataxia: Competitive Landscape
Post-operative Pain: Competitive Landscape
The Role of CAR-T Cells in Systemic Lupus Erythematosus
ESCMID Global 2024: The Infectious Consequences of Climate Change
ESCMID Global 2024: Highlights on Prophylaxis and Treatment of Infectious Diseases
HER2-Positive Breast Cancer: Epidemiology Forecast to 2033
ESCMID Global 2024: Long-Acting Injectables for HIV Prevention
ESCMID Global 2024: Emerging Bacterial Infections in Neonates and Children
Osteoporosis: Epidemiology Forecast to 2033
컨퍼런스/
심포지엄/
학회/기타
(4건)		 ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
The Wolbachia Method in the Battle Against Dengue
ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
Extended Time Spent Indoors in School Increases the Risk of Shortsightedness

​

반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
반응형
구분 보고서 (영문)
제약/
바이오/
임상시험
(3건)		 FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
New Drug Approvals and Their Contract Manufacture: 2024 Edition
Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
질환별
(8건)		 Cell & Gene Therapies in Rheumatology
Acne Vulgaris: Competitive Landscape
Study Explores the Effects of State Medicaid Policies on Hepatitis C Treatment
Methicillin-Resistant Staphylococcus aureus (MRSA): Epidemiology Forecast to 2033
Changing Epidemiology of Atopic Dermatitis in South Korea
New WHO Hepatitis B Guidelines Address Testing and Treatment Barriers
Syphilis, the Once Near-Eliminated STI, Is Resurging in the US
PPD Affects Races Similarly, Inequities Lie in Mental Healthcare
컨퍼런스/
심포지엄/
학회/기타
(13건)		 ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
The Wolbachia Method in the Battle Against Dengue
ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
Extended Time Spent Indoors in School Increases the Risk of Shortsightedness
India Sees Insignificant Revision to Price Ceiling in 2024
AAN 2024: Myostatin Inhibitors on the Horizon for the Treatment of SMA
AAN 2024: Amneal Showcases IPX203’s Safety Profile in Anticipation of FDA Approval
AAN 2024: AbbVie Highlights Long-Term Safety of Atogepant in Migraine Prevention
AAN 2024: Biomarker Data Shows Promise for Alzheon’s Oral Anti-Amyloid Drug
AAN 2024: Importance of Early Diagnosis and Prompt Treatment in SMA
AAN 2024: Four-Year Follow-Up of Roche’s PRX-002 Encouraging for Parkinson’s Disease
AAN 2024: New Pooled Data Highlights Efficacy of Axsome Therapeutics’s AXS-07
AAN 2024: Pharma Two B’s P2B001 Shows Promise in Early PD
AAN 2024: Monitoring Adverse Events Associated with Gene Transfer Therapies

 

반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02

+ Recent posts

티스토리툴바